Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05204888 · ClinicalTrials.gov registry record · NA
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
A NA study of COPD, sponsored by Temple University.
- Recruiting
- Registry status
- NA
- Development phase
- 642
- Enrollment target
- 20
- Study locations
NCT05204888: Recruiting NA study of COPD, sponsored by Temple University.
NCT05204888 is a NA study of COPD that is actively recruiting participants, run by Temple University. The registered enrollment target is 642 participants, below the 2,411-participant average among 85 other COPD trials with a reported enrollment target (73% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05204888, a NA study of COPD, is actively recruiting participants, sponsored by Temple University.
- RECRUITING
- Registry status
- NA
- Development phase
- 642 participants
- Enrollment target
- 20
- Study locations
Study Summary
Parallel-group, prospective, randomized, controlled phase III trial of home High flow Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical care, for at least 1 year and up to two years in 642 GOLD Grade D, Stages II-IV patients with moderate to very severe COPD at risk for moderate and severe exacerbations with a prior history of severe exacerbation requiring hospitalization within the past 6 weeks.
Primary Outcome
Time to first moderate or severe COPD exacerbation
Conditions Studied
Interventions
- DEVICE Pulse oximeter
- DEVICE myAirvo3
Study Locations (20)
Florida
- University of Florida, Jacksonville - Jacksonville
- Alloy Clinical Research - Kissimmee
- Reliable Research, Inc. - Miami
- NewGen Health Group - Miami
- Destiny Research - Palmetto Bay
Ohio
- Cincinnati VA Medical Center - Cincinnati
- Cleveland Clinic Foundation - Cleveland
- Ohio State University Wexner Medical Center - Columbus
Pennsylvania
- St. Luke's University Health Network - Bethlehem
- Clinical Research Associates of Central Pennsylvania - DuBois
- Jeanes Hospital - Philadelphia
Massachusetts
- Tufts Medical Center - Boston
- Lahey Hospital and Medical Center - Burlington
Alabama
- UAB School of Medicine/Lung Health Center - Birmingham
Arizona
- Honor Health - Scottsdale
Illinois
- University of Chicago - Chicago
Iowa
- The Iowa Clinic - West Des Moines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 642 participants |
| Start Date | 2022-02-02 |
| Est. Completion | 2027-03 |
| Phase | NA |
What NCT05204888 shows while recruiting
NCT05204888 is an interventional study that assigns participants to a tested intervention. The registered 642 participants enrollment target is mid-sized for trials with a published cap, below the 2,411-participant average among 85 other COPD trials with a reported enrollment target (73% lower).
The record links to 1 condition, with COPD appearing as the primary indexed condition, and to 2 interventions - of which Pulse oximeter is the first listed.
NCT05204888 names 20 study sites across 11 states, led by Florida, Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05204888 about?
NCT05204888 is a clinical study titled "myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home". Parallel-group, prospective, randomized, controlled phase III trial of home High flow Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical care, for at least 1 year and up to two years in 642 GOLD Grade D, Stages II-IV patients with moderate to very severe COPD at r...
What is the current status of trial NCT05204888?
This trial is currently recruiting. It is a NA study. The enrollment target is 642 participants. The study started on 2022-02-02. Estimated completion is 2027-03.
What conditions does trial NCT05204888 study?
This clinical trial studies the following conditions: COPD.
What interventions are being tested in trial NCT05204888?
The interventions under investigation include: Pulse oximeter (DEVICE), myAirvo3 (DEVICE).
Who is sponsoring clinical trial NCT05204888?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05204888 being conducted?
This trial has 20 study locations across Alabama, Arizona, Florida, Illinois, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05204888's enrollment target sits among peer trials
642 15th of 85 higher than 71 of 85 other COPD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
The Reducing REVISITS Study: A Cluster RCT
RECRUITING · NA
-
The Effect of a Technology-Mediated Integrated Walking and Tai Chi Intervention on Physical Function in Veterans With COPD and Chronic Musculoskeletal Pain
RECRUITING · NA
-
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06319820 · 641 participants · Phase 3
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
- NCT06625060 · 641 participants · Phase 2
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
- NCT05146297 · 644 participants · NA
Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials
- NCT06994442 · 644 participants · Phase 3
Optimizing Pain Treatment in Children On Mechanical Ventilation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI